SA
ARKAY logo
Arkema S.A.(ARKAY)
Closing price · checked 10:12 PM ETAbout this dataData status
$58.64▼-2.36 (-3.87%)
Extended:$59.08+0.44 (+0.75%)· 10:12 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Arkema S.A. (ARKAY)

Net Acquisitions

€2.78M

TTM · Period ending: · EUR

ARKAY logo

ARKAY Net Acquisitions

Latest reported€2.78M EUR
ARKAY Net Acquisitions · EUR (-€11.00M → €2.78M)
Powered by
High-resolution chart · PNG

What is net acquisitions?

Cash spent on business acquisitions (net).

ARKAY net acquisitions history

Annual fiscal periods · EUR. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Arkema S.A. Net Acquisitions — Annual fiscal periods (EUR)
Period endingNet Acquisitions (EUR)Change
17,289,588—
-147,000,000—
-682,000,000—
-1,597,000,000−242.46%
1,121,000,000+1,021.00%
100,000,000—
-714,000,000—
-201,000,000−2,110.00%
10,000,000—
-295,000,000—
-1,191,000,000—
-189,000,000—
-14,000,000—
-270,000,000—
-580,000,000—
-18,000,000—
0—
-18,000,000—
-105,000,000—
-7,000,000—
-3,000,000—
-11,000,000—

Frequently asked questions: ARKAY net acquisitions

What is Arkema S.A. (ARKAY)'s current net acquisitions?

Arkema S.A. (ARKAY)'s latest reported net acquisitions (TTM) is €2.78M as of Sep 30, 2026. Cash spent on business acquisitions (net).

How much historical net acquisitions data is available for ARKAY?

Stock Alarm Pro provides 22 dated annual fiscal periods observations for Arkema S.A. (ARKAY)'s net acquisitions, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare ARKAY's net acquisitions to peers or set an alert?

You can open ARKAY's net acquisitions in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on ARKAY delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.